Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ABBV

AbbVie

$87.49

-1.13 (-1.28%)

13:00
12/13/18
12/13
13:00
12/13/18
13:00
Hot Stocks
AbbVie announces $5B boost to stock repurchase program »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLPG

Galapagos NV

$106.90

4.5 (4.39%)

, ABBV

AbbVie

$88.62

0.45 (0.51%)

08:14
12/13/18
12/13
08:14
12/13/18
08:14
Upgrade
Galapagos NV, AbbVie rating change  »

Galapagos NV upgraded to…

GLPG

Galapagos NV

$106.90

4.5 (4.39%)

ABBV

AbbVie

$88.62

0.45 (0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a week ago
ABBV

AbbVie

$90.55

-3.15 (-3.36%)

16:20
12/05/18
12/05
16:20
12/05/18
16:20
Hot Stocks
AbbVie reports Phase 3 TAHOE trial halted »

AbbVie announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABBV

AbbVie

$93.61

-0.09 (-0.10%)

11:58
12/04/18
12/04
11:58
12/04/18
11:58
Hot Stocks
AbbVie Phase 3 study shows significantly prolonged progression-free survival »

AbbVie shared results…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNTA

Momenta

$12.07

0.26 (2.20%)

, ABBV

AbbVie

$93.64

(0.00%)

16:11
12/03/18
12/03
16:11
12/03/18
16:11
Hot Stocks
Momenta provides update on U.S. regulatory strategy for Humira biosimilar »

Momenta Pharmaceuticals…

MNTA

Momenta

$12.07

0.26 (2.20%)

ABBV

AbbVie

$93.64

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$145.72

-0.87 (-0.59%)

, ABBV

AbbVie

$93.17

-0.47 (-0.50%)

14:19
12/03/18
12/03
14:19
12/03/18
14:19
Hot Stocks
AbbVie says Imbruvica Phase 3 combo data finds improvement in PFS »

AbbVie (ABBV) announced…

JNJ

Johnson & Johnson

$145.72

-0.87 (-0.59%)

ABBV

AbbVie

$93.17

-0.47 (-0.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 12

    Dec

  • 12

    Dec

ABBV

AbbVie

$93.64

3.72 (4.14%)

17:50
12/02/18
12/02
17:50
12/02/18
17:50
Hot Stocks
AbbVie announces results of up to 7 years of PFS of trial follow-up in CLL/SLL »

AbbVie announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABBV

AbbVie

$93.64

3.72 (4.14%)

, RHHBY

Roche

$0.00

(0.00%)

14:02
12/02/18
12/02
14:02
12/02/18
14:02
Hot Stocks
AbbVie presents new data from Phase 3 MURANO trial of VENCLEXTA/VENCLYXTO »

AbbVie (ABBV) presented…

ABBV

AbbVie

$93.64

3.72 (4.14%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

  • 03

    Dec

  • 03

    Dec

  • 24

    Dec

ABBV

AbbVie

$93.64

3.72 (4.14%)

, MEIP

MEI Pharma

$2.88

0.01 (0.35%)

12:39
12/02/18
12/02
12:39
12/02/18
12:39
Hot Stocks
MEI data shows Voruciclib synergistically induces apoptosis in Venetoclax combo »

MEI Pharma (MEIP)…

ABBV

AbbVie

$93.64

3.72 (4.14%)

MEIP

MEI Pharma

$2.88

0.01 (0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABBV

AbbVie

$90.04

0.12 (0.13%)

, PFE

Pfizer

$45.64

0.13 (0.29%)

10:02
11/30/18
11/30
10:02
11/30/18
10:02
Hot Stocks
AbbVie signs patent license agreements with Pfizer over Humira biosimilar »

AbbVie (ABBV) announced…

ABBV

AbbVie

$90.04

0.12 (0.13%)

PFE

Pfizer

$45.64

0.13 (0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Dec

  • 02

    Dec

  • 03

    Dec

  • 10

    Dec

  • 18

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.